Circulating Circular RNAs: Novel Biomarkers for Heart Failure

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiology

Background:

• Heart failure (HF) is a critical global health issue with high mortality.
• Current HF strategies focus on preventing disease progression rather than healing.
• Noncoding RNAs (ncRNAs), particularly circular RNAs (circRNAs), are emerging as key players in HF pathogenesis.

Purpose of the Study:

• To review current advancements in using circRNAs as biomarkers for HF diagnosis and treatment.
• To highlight the potential of circRNAs in managing heart failure.
• To identify future research directions for circRNAs in HF.

Main Methods:

• Literature review of recent studies on circRNAs and heart failure.
• Synthesis of current knowledge on circRNA applications in HF.
• Analysis of existing data on circRNAs as diagnostic and therapeutic targets.

Main Results:

• Circular RNAs (circRNAs) are increasingly recognized for their significant role in heart failure (HF).
• Evidence suggests circRNAs hold potential as novel biomarkers for HF diagnosis.
• circRNAs may offer new therapeutic avenues for treating HF.

Conclusions:

• circRNAs represent a promising area for developing new diagnostic and therapeutic strategies for heart failure.
• Continued investigation into circRNAs is crucial for advancing HF care.
• Future research should focus on validating circRNAs as reliable HF biomarkers and therapeutic targets.